PARTICLE DRILLING TECHNOLOGIES, INC. SECURITIES PURCHASE AGREEMENT

Exhibit 10.1

EXECUTION COPY

PARTICLE DRILLING TECHNOLOGIES, INC.

This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of October 19, 2006, is by and among PARTICLE DRILLING TECHNOLOGIES, INC., a Nevada corporation (the “Company”), and each of the investors signatory hereto and listed for convenience on Schedule I hereto (each of the persons or entities listed on Schedule I, individually, a “Purchaser” and, collectively, the “Purchasers”).

WHEREAS, the Company desires to issue and sell to the Purchasers, and the Purchasers desire to purchase from the Company, severally and not jointly, an aggregate of (i) 5,000,000 shares (the “Shares”) of the authorized but unissued shares of the Company’s common stock, $0.001 par value per share (including any securities into which or for which such shares may be exchanged for, or converted into, pursuant to any stock dividend, stock split, stock combination, recapitalization, reclassification, reorganization or other similar event, the “Common Stock”) and (ii) warrants to purchase 1,500,000 shares of Common Stock (the “Warrants”), at an aggregate purchase price of $11,750,000, all upon the terms and subject to the conditions set forth in this Agreement; and

WHEREAS, simultaneously with entering into this Agreement, the Company and the Purchasers are entering into that certain Registration Rights Agreement, dated as of the date hereof (the “Registration Rights Agreement”), pursuant to which the Company will assume obligations with respect to the registration of the Shares and Warrant Shares on the terms set forth therein.

NOW THEREFORE, in consideration of the mutual agreements, representations, warranties and covenants herein contained, the parties hereto agree as follows:

1. Definitions; Certain Rules of Construction. As used in this Agreement, the following terms shall have the following respective meanings:

“Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this Agreement, “control,” when used with respect to any specified Person means the power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.

“Board” means the board of directors of the Company.

“business day” (whether such term is capitalized or not) means any day except Saturday, Sunday and any day which shall be a federal legal holiday or a day on which banking institutions in the State of New York or the State of Texas are authorized or required by law or other governmental action to close.

“Closing Date” means the date hereof.

“Code” means the Internal Revenue Code of 1986.

“Effective Date” shall mean the date either (i) the Mandatory Registration Statement or (ii) another registration statement that registers the resale by, and for the account of, each Purchaser as an initial selling stockholder (or any transferee thereof) of the Shares and the Warrant Shares under the Securities Act, is first declared effective by the SEC.

“Environmental Protection Laws” means any law, statute or regulation enacted by any jurisdiction in connection with or relating to the protection or regulation of the environment, including, without limitation, those laws, statutes and regulations regulating the disposal, removal, production, storing, refining, handling, transferring, processing or transporting of hazardous or toxic substances, and any orders, decrees or judgments issued by any court of competent jurisdiction in connection with any of the foregoing.

“ERISA” means the Employee Retirement Income Security Act of 1974.

“ERISA Affiliate” means any Person required to be aggregated with the Company or any Subsidiary of the Company under Sections 414(b), (c), (m) or (o) of the Code.

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and all of the rules and regulations promulgated thereunder.

“Exchange Act Reports” means the Company’s reports filed with the SEC pursuant to Section 13 of the Exchange Act at any time on or after October 15, 2004.

“Governmental Authority” means any nation or government, any state or other political subdivision thereof and any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government.

“Indebtedness” means, as applied to any Person, all indebtedness for borrowed money, whether current or funded, or secured or unsecured.

“Lien” means, with respect to any property or asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in respect of such property or asset, whether or not filed, recorded or otherwise perfected under applicable law, other than (a) those resulting from taxes which have not yet become delinquent, (b) minor liens and encumbrances that do not materially detract from the value of the property or materially impair the operations of the Company or materially interfere with the use of such property or asset or (c) those relating to Indebtedness incurred prior to the date hereof and any replacement thereof.

“Majority Purchasers” means Purchasers holding, at any time, a majority of the outstanding Shares purchased hereunder on such date.

“Mandatory Effective Date” shall have the meaning assigned to such term in the Registration Rights Agreement.

“Mandatory Registration Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.

“Material Adverse Effect” means a material adverse effect on the business, assets, liabilities (contingent or otherwise), properties, operations, prospects or condition (financial or otherwise) of the Company and its Subsidiaries taken as a whole or a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under this Agreement, the Warrants or the Registration Rights Agreement.

“Offering Memorandum” means the Private Placement Memorandum of the Company, dated as of October 17, 2006.

“PBGC” means the Pension Benefit Guaranty Corporation.

“PDTI” means Particle Drilling Technologies, Inc., a Delaware corporation and Subsidiary of the Company.

“Person” (whether or not capitalized) means an individual, entity, partnership, limited liability company, corporation, association, trust, joint venture, unincorporated organization, and any Governmental Authority.

“Plan” means any employee benefit plan, program or arrangement, whether oral or written, maintained or contributed to by the Company, any Subsidiary of the Company or any ERISA Affiliate, or with respect to which the Company, any Subsidiary of the Company or any ERISA Affiliate may incur liability.

“Registration Statements” means the Company’s registration statements filed with the SEC pursuant to the Securities Act at any time on or after October 15, 2004.

“Rule 144” means Rule 144 promulgated under the Securities Act and any successor or substitute rule, law or provision.

“SEC” means the United States Securities and Exchange Commission.

“SEC Reports” means the Exchange Act Reports and the Registration Statements.

“Securities Act” means the Securities Act of 1933, as amended, and all of the rules and regulations promulgated thereunder.

“Short Sales” shall include all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act.

“Subsidiary” means with respect to any Person at any time, (a) any other Person the accounts of which would be consolidated with those of such first Person in its consolidated

financial statements as of such time, and (b) any other Person (i) which is, at such time, controlled by, or (ii) capital securities of which having ordinary voting power to elect a majority of the board of directors (or other persons having similar functions), or other ownership interest of which ordinarily constituting a majority voting interest, are at such time, directly or indirectly, owned or controlled by, in the case of each of clauses (i) and (ii), such first Person or one or more of its Subsidiaries or by such first Person and one or more of its Subsidiaries. Unless otherwise expressly provided, all references herein to “Subsidiary” means a Subsidiary of the Company.

“Transfer Agent Instruction Letter” means the letter, dated as of the Closing Date, from the Company to its transfer agent in the form attached hereto as Exhibit E.

“Warrant Shares” means the shares of Common Stock issuable upon exercise of the Warrants in accordance with their terms.

“in writing” means any form of written communication or a communication by means of facsimile transmission.

The following table sets forth certain other defined terms and the section of this Agreement in which the meaning of each such term appears:

		Section(s)
“Aggregate Purchase Price”		2.1
“Agreement”		Preamble
“Closing”		2.2
“Common Stock”		Preamble
“Company”		Preamble
“Disclosure Schedules”		3
“Intellectual Property”		3.27
“Losses”		7.1
“Permits”		3.20
“Purchase Price Per Share”		2.1
“Purchaser”		Preamble
“Purchaser Indemnitee”		7.1
“Registration Rights Agreement”		Preamble
“▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act”		3.21
“Securities Laws Exemption”		3.32
“Shares”		Preamble
“8-K Filing”		6.3

2. Purchase and Sale of Shares.

2.1 Purchase and Sale. Subject to and upon the terms and conditions set forth in this Agreement, the Company agrees to issue and sell to each Purchaser, and each Purchaser hereby agrees, severally and not jointly, to purchase from the Company, at the Closing, the number of Shares set forth on the Purchaser’s signature page hereto, and repeated for convenience only opposite such Purchaser’s name on Schedule I hereto, at a purchase price equal to $2.35 per Share (the “Purchase Price Per Share”). In addition, in connection with the purchase of the Shares pursuant to this Agreement, the Company shall issue to such Purchaser a Warrant to purchase such number of Warrant Shares as is equal to (x) the number of Shares purchased by such Purchaser multiplied by (y) 0.3, which Warrant shall entitle the holder thereof to purchase Warrant Shares at an exercise price equal to $3.25 per Warrant Share pursuant to the terms of the Warrant. The aggregate purchase price payable by the Purchasers to the Company for all of the Shares and Warrants shall be $11,750,000 (the “Aggregate Purchase Price”).

2.2 Closing. The closing of the transactions contemplated under this Agreement (the “Closing”) shall take place at 5:30 pm (Eastern Time) at the offices of ▇▇▇▇▇▇ & ▇▇▇▇▇▇ L.L.P., Houston, Texas, on the Closing Date, or on such other date and at such time as may be agreed upon between the Purchasers, on the one hand, and the Company, on the other hand. Promptly following the Closing, the Company shall deliver to each Purchaser a single stock certificate and a single Warrant certificate, in each case registered in the name of such Purchaser, representing the number of Shares and Warrants purchased by such Purchaser, against payment by such Purchaser at the Closing of its respective aggregate Purchase Price Per Share by wire transfer of immediately available funds to such account as the Company shall designate in advance in writing, which stock and Warrant certificates shall bear the legend set forth in Section 6.2(a). The stock and Warrant certificates delivered to the Purchasers and representing the Shares and Warrants will be registered in the names and addresses of the Purchasers set forth on the signature page hereto.

3. Representations and Warranties of the Company. In order to induce the Purchasers to enter into this Agreement and to purchase the Shares, except as set forth in the corresponding sections of the Disclosure Schedules delivered concurrently herewith (the “Disclosure Schedules”), the Company hereby makes the following representations and warranties as of the Closing Date, all of which shall survive the execution and delivery of this Agreement and the purchase of the Shares and Warrants:

3.1 Corporate Status. Each of the Company and its Subsidiaries (a) is duly incorporated, validly existing and in good standing under the laws of the jurisdiction of its organization and has the corporate power and authority to own its property and assets and to transact the business in which it is engaged and presently proposes to engage and (b) has been duly qualified to do business and is in good standing in each jurisdiction where it is required to be so qualified and where the failure to be so qualified would reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is currently in violation of any of the provisions of its certificate of incorporation (or other charter document) or by-laws, each as amended to date.

3.2 Corporate Power and Authority. All corporate action on the part of the Company, its officers, directors and shareholders necessary for the authorization, execution, delivery and performance of this Agreement, the Warrants and the Registration Rights Agreement and the consummation of the transactions contemplated herein and therein has been taken. When executed and delivered by the Company, each of this Agreement, the Warrants and the Registration Rights Agreement shall constitute the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such may be limited by bankruptcy, insolvency, reorganization or other laws affecting creditors’ rights generally and by general equitable principles. The Company has all requisite corporate power and authority to enter into this Agreement, the Warrants and the Registration Rights Agreement and to carry out and perform its obligations under the terms hereof and thereof.

3.3 No Violation. Neither the execution, delivery and performance by the Company of this Agreement, the Warrants and the Registration Rights Agreement nor compliance with the terms and provisions hereof and thereof (a) will contravene any applicable provision of any law, statute, rule, regulation, order, writ, injunction or decree of any court or Governmental Authority, except as would not have a Material Adverse Effect, (b) will conflict with or result in any breach of, any of the material terms, covenants, conditions or provisions of, or constitute a default under, or result in the creation or imposition of (or the obligation to create or impose) any Lien upon any of the property or assets of the Company or any of its Subsidiaries pursuant to the terms of, any indenture, mortgage, deed of trust, agreement or other instrument to which the Company or any of its Subsidiaries is a party or by which it or any of its or their property or assets are bound or to which it may be subject or result in the acceleration of any material obligation of the Company or any of its Subsidiaries, except as would not have a Material Adverse Effect or (c) will violate any provision of the certificate of incorporation (or other charter documents) or by-laws of the Company or any of its Subsidiaries, each as amended to date.

3.4 Capitalization.

(a) As of the date hereof, the authorized capital stock of the Company consists of 100,000,000 shares of Common Stock, of which 25,018,950 shares are issued and outstanding. As of the date hereof, 5,559,891 shares of Common Stock were reserved for future issuance pursuant to outstanding options and warrants issued by the Company.

(b) As of the date hereof, the authorized capital stock of PDTI, the only Subsidiary of the Company, consists of 50,000,000 shares of common stock and 20,000,000 shares of preferred stock, of which 50,000,000 shares of common stock and no shares of preferred stock are issued and outstanding, and all of the issued and outstanding shares of common stock of PDTI are owned by the Company, free and clear of any Liens. As of the date hereof, no shares of capital stock of any of the Subsidiaries of the Company were reserved for future issuance pursuant to outstanding options, warrants or other rights to acquire shares of capital stock of any of the Subsidiaries of the Company issued by any of the Subsidiaries of the Company.

(c) As of the date hereof, except as set forth above in (a) and (b), and for the exercise rights of the Warrants, there are no other outstanding options, warrants, rights (including

conversion or preemptive rights) or any agreement for the purchase or acquisition from the Company or any of its Subsidiaries of any shares of the Company’s or any of its Subsidiaries’ capital stock or voting agreements with respect to equity of the Company or any of its Subsidiaries. All shares of the capital stock of the Company and its Subsidiaries subject to issuance as aforesaid, upon issuance on the terms and conditions specified in the instruments pursuant to which they are issuable, shall, to the knowledge of the Company after due inquiry, be duly authorized, validly issued, fully paid and nonassessable. Except as disclosed in Section 3.4(c) of the Disclosure Schedules or in the SEC Reports or as set forth above in (a) and (b), there are no obligations, contingent or otherwise, of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any shares of Common Stock or other equity securities of the Company or any of its Subsidiaries or to provide funds to or make any investment (in the form of a loan, capital contribution, guaranty or otherwise) in any other entity. The sale of the Shares and the issuance of the Warrants under this Agreement, and the issuance of any Warrant Shares upon exercise of the Warrants in their current form, will not result in the Company or any of its Subsidiaries being obligated to issue, sell or purchase, pursuant to any existing preemptive, anti-dilution, redemption or other right of third parties, shares of Common Stock or other securities to or from any Person (other than the Purchasers), and will not result in a right of any holder of convertible or contingent securities issued by the Company or any of its Subsidiaries to adjust the exercise, conversion, exchange or reset price under such securities, including, in any such case, pursuant to any “poison pill” or shareholders rights plan. To the knowledge of the Company after due inquiry, none of the outstanding shares of capital stock of the Company or any of its Subsidiaries were issued in violation of the Securities Act or any state securities laws.

3.5 Valid Issuance of the Shares. The Shares, the Warrants and the Warrant Shares have been duly authorized, and the Shares and Warrant Shares, upon issuance pursuant to the terms hereof and of the Warrants as to the Warrant Shares, (a) will be validly issued, fully paid and nonassessable, (b) will not be subject to any encumbrances, preemptive rights or any other similar contractual rights of the stockholders of the Company or any other Person, and (c) the applicable Purchaser (with respect to the Shares) and the applicable Holder (as defined in the Warrant) will obtain sole record and beneficial ownership of such Shares and Warrant Shares (as applicable) and take good marketable title thereto, free and clear of any Liens (defined for purposes hereof without regard to the carve-outs set forth in clauses (a) through (c) of the definition of Lien), claims, charges, taxes, options or transfer restrictions of any kind, other than those transfer restrictions explicitly set forth in this Agreement and in the Warrants. The Company has reserved from its duly authorized capital stock the number of shares of Common Stock issuable upon execution of this Agreement and upon exercise in full of the Warrants (assuming the Warrants vest in full).

3.6 Litigation. Except as disclosed in the SEC Reports, no actions, suits, claims, investigations or proceedings are pending or, to the Company’s knowledge, threatened that could reasonably be expected to have, individually or in the aggregate (a) a Material Adverse Effect or (b) an adverse effect on the rights or remedies of the Purchasers or on the ability of the Company or its Subsidiaries to perform when due to be performed their respective obligations under this Agreement, the Warrants or the Registration Rights Agreement. Except as disclosed in Section 3.6 of the Disclosure Schedules or the SEC Reports, neither the Company nor any of its Subsidiaries is a party to or named in or subject to any order, writ, injunction, judgment or decree of any court or Governmental Authority. Except as disclosed in Section 3.6

of the Disclosure Schedules or the SEC Reports, there is no action, suit, claim, proceeding or investigation by the Company or any of its Subsidiaries currently pending or that the Company or any of its Subsidiaries currently intends to initiate.

3.7 Approvals. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 4 below and in the Investor Questionnaire executed and delivered by each Purchaser to the Company, such Investor Questionnaire in the form attached hereto as Exhibit A, except for (a) any required filings and recordings which have been made and are in full force and effect, (b) the filing of a registration statement with the SEC pursuant to the Registration Rights Agreement and (c) applicable blue sky notice filings or a Form D to be timely filed with the SEC, no order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by, any Person or Governmental Authority, is required to authorize or is required for or as a condition to (i) the execution, delivery and performance of this Agreement, the Warrants or the Registration Rights Agreement or (ii) the legality, validity, binding effect or enforceability of this Agreement, the Warrants or the Registration Rights Agreement. The execution and delivery by the Company of this Agreement, the Warrants and the Registration Rights Agreement, the consummation of the transactions contemplated herein and therein, and the issuance of the Shares, the Warrants, and upon exercise of the Warrants, the Warrant Shares, does not require the consent or approval of the stockholders of the Company or any other Person.

3.8 Contracts. All material agreements to which the Company or any of its Subsidiaries is a party or to which the property or assets of the Company or any of its Subsidiaries are subject are included as part of or specifically identified in the SEC Reports to the extent required by the rules and regulations of the SEC as in effect at the time of filing of such SEC Reports. Except as disclosed in Section 3.8 of the Disclosure Schedules or in the SEC Reports, all such material agreements required to be filed as exhibits to the SEC Reports are legal, valid and binding obligations of the Company in accordance with their respective terms and, to the knowledge of the Company, the other parties thereto, except in any case as may be limited by bankruptcy, insolvency, reorganization or other laws affecting creditors’ rights generally and by general equitable principles. The Company and its Subsidiaries are not, nor to their knowledge is any counterparty, in violation of or default under, any agreement to which any of them is a party, except as would not reasonably be expected to have a Material Adverse Effect.

3.9 Conformity to Securities Act and Exchange Act; No Misstatement or Omission. To the knowledge of the Company after due inquiry, each of the SEC Reports as of the date it was filed with the SEC in the case of filings under the Exchange Act or declared effective in the case of the Registration Statements, complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as applicable) and the respective rules and regulations of the SEC thereunder and did not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading. To the knowledge of the Company after due inquiry, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements of the Exchange Act at any time on or after October 15, 2004.

3.10 Financial Statements; Indebtedness.

(a) The consolidated financial statements of the Company for the year ended September 30, 2005, and the most recent consolidated financial statements for the quarter ended June 30, 2006, are complete and correct and present fairly in all material respects the consolidated financial position of the Company as of the dates specified and the consolidated results of their operations and cash flows for the periods specified, in each case, in conformity with generally accepted accounting principles applied on a consistent basis during the periods involved, except as indicated therein or in the notes thereto.

(b) Except as set forth in Section 3.10(b) of the Disclosure Schedules or in the financial statements included in the SEC Reports, the Company and its Subsidiaries have no Indebtedness outstanding at the date hereof. Except as set forth in Section 3.10(b) of the Disclosure Schedules, none of the Company or its Subsidiaries is in default with respect to any outstanding Indebtedness or any instrument relating thereto, and no event has occurred, or facts and circumstances exist, which, after passage of time, would result in such a default.

3.11 Margin Regulations. Neither the sale of the Shares and Warrants, nor the use of the proceeds thereof, will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System.

3.12 Investment Company Act. The Company is not an “investment company” or a company “controlled” by an “investment company,” within the meaning of the Investment Company Act of 1940.

3.13 No Material Adverse Changes. Since September 30, 2005, except as described in the SEC Reports or otherwise set forth in Section 3.13 of the Disclosure Schedules, (a) no event has occurred which has had, or could reasonably be expected to have, a Material Adverse Effect; (b) except as contemplated by this Agreement, there has been no transaction entered into by the Company or any of its Subsidiaries other than transactions in the ordinary course of business or transactions which would not, individually or in the aggregate, be material to the Company; (c) there have not been any changes in the Company’s or any of its Subsidiaries’ authorized capital or any increases in the Indebtedness of the Company and its Subsidiaries taken as a whole; (d) there has been no actual or, to the knowledge of the Company, threatened revocation of, or default under, any contract to which the Company or any of its Subsidiaries is a party, except as would not have a Material Adverse Effect; (e) there have not been any amendments or changes in the charter documents or by-laws of the Company or any of its Subsidiaries; (f) there have not been any entry into, amendment of, relinquishment, termination or non-renewal by the Company or any of its Subsidiaries of any material contract, license, lease, transaction, commitment or other right or obligation, other than in the ordinary course of business, consistent with past practice; (g) the Company has not declared or paid any dividend on any class of its capital stock; and (h) there has not been any transfer or grant of a right with respect to the Intellectual Property owned or licensed by the Company or any of its Subsidiaries, except as among the Company and its Subsidiaries.

3.14 Tax Returns and Payments. Except as set forth in Section 3.14 of the Disclosure Schedules, each of the Company and each of its Subsidiaries has filed all federal

income tax returns and all other domestic and foreign tax returns and reports required to be filed by it and has paid all taxes and assessments payable by it which have become due, except for those contested in good faith and adequately reserved against (in the good faith determination of the Company), all of which, to the extent outstanding on the Closing Date, have been disclosed by the Company in the SEC Reports. All such returns and reports are true and correct in all material respects. Each of the Company and each of its Subsidiaries has paid, or has provided adequate reserves (in the good faith judgment of the Company) for the payment of, all material federal, state and foreign taxes that are not yet due and payable for all fiscal years, including the current fiscal year, to date. No action, suit, proceeding, investigation, audit or claim is now pending or, to the knowledge of the Company or its Subsidiaries, threatened by any authority regarding any taxes relating to the Company or any of its Subsidiaries which could reasonably be expected to have a Material Adverse Effect. As of the Closing Date, neither the Company nor any of its Subsidiaries has entered into an agreement or waiver or been requested to enter into an agreement or waiver extending any statute of limitations relating to the payment or collection of taxes of the Company or any of its Subsidiaries. No tax return of the Company or any of its Subsidiaries is or has been the subject of an audit or examination by any taxing authority, other than any such audit or examination which has been completed or closed. Each of the Company and its Subsidiaries has withheld from each payment made to any of its past or present employees, officers and directors, and any other Person, the amount of all material taxes and other deductions required to be withheld therefrom and paid the same to the proper taxing authority within the time required by law.

3.15 Subsidiaries. As of the Closing Date, the Company has no directly or indirectly held Subsidiary other than PDTI. All such shares of PDTI have been duly authorized, validly issued and are fully paid and nonassessable. As of the Closing Date, the Company is not party to any joint venture or similar arrangement.

3.16 Properties. The Company and each of its Subsidiaries owns its properties and assets free and clear of all Liens. With respect to leased property and assets, the Company and its Subsidiaries are in compliance with such leases and hold a valid leasehold interest, free and clear of any Liens.

3.17 Labor Relations. The Company and its Subsidiaries are not engaging in any unfair labor practice. No unfair labor practice complaint is pending against the Company or any of its Subsidiaries or, to the best of its knowledge, threatened against it or any of its Subsidiaries, before the National Labor Relations Board or similar foreign labor relations authority, and no grievance or arbitration proceeding arising out of or under any collective bargaining agreement is so pending against the Company or any of its Subsidiaries, or, to the best of its knowledge, threatened against it or any of its Subsidiaries. No strike, labor dispute, slowdown or stoppage is pending against the Company or any of its Subsidiaries or, to the best of its knowledge, threatened against the Company or any of it Subsidiaries. No union representation question exists with respect to the employees of the Company or any of its Subsidiaries and no union organizing activities are taking place. The Company and its Subsidiaries have complied in all material respects with all applicable state and federal equal opportunity and other laws related to employment. To the Company’s knowledge, no employee of the Company or any of its Subsidiaries is or will be in violation of any judgment, decree, or order, or any term of any employment contract, patent disclosure agreement, or other contract or agreement relating to the

relationship of any such employee with the Company or any of its Subsidiaries, or any other party because of the nature of the business presently conducted or presently proposed to be conducted by the Company and its Subsidiaries. The Company is not aware that any officer or key employee, or that any group of key employees, intends to terminate their employment with the Company or any of its Subsidiaries, nor does the Company or any of its Subsidiaries have a present intention to terminate the employment of any of the foregoing. Subject to general principles related to wrongful termination of employees, the employment of each officer and employee of the Company and its Subsidiaries is terminable at the will of the Company or the applicable Subsidiary.

3.18 Compliance with Law. The conduct of the Company’s business complies with all applicable U.S., state, local and foreign laws, ordinances, rules, regulations, and orders, except where the failure to so comply would not reasonably be expected to have a Material Adverse Effect.

3.19 Permits. The Company and its Subsidiaries have all franchises, permits, licenses, certificates, registrations and any similar authority (the “Permits”) necessary or material for the conduct of their business as described in the SEC Reports, the lack of which could, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. As of the date hereof, no suspension or cancellation of any of the Permits is pending or, to the knowledge of the Company, threatened which could, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company believes it can obtain, without undue burden or expense, any similar authority for the conduct of its business as presently proposed to be conducted. The Company and its Subsidiaries are not in default under any of such franchises, permits, licenses or other similar authorities.

3.20 ERISA. Neither the Company, any of its Subsidiaries nor any ERISA Affiliate maintains or contributes to any Plan other than those listed in Section 3.20 of the Disclosure Schedules.

(a) Compliance with ERISA. The Company and each ERISA Affiliate is in compliance with ERISA, except for such failures to comply that, in the aggregate for all such failures, would not reasonably be expected to have a Material Adverse Effect, and no contributions required to be made by the Company or any ERISA Affiliate to any pension plan are overdue.

(b) PBGC. No liability to the PBGC has been or is expected to be incurred by the Company or any ERISA Affiliate with respect to any pension plan that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. No circumstance exists that constitutes grounds under section 4042 of ERISA entitling the PBGC to institute proceedings to terminate, or appoint a trustee to administer, any pension plan or trust created thereunder, nor has the PBGC instituted any such proceeding.

(c) Multiemployer Plans. Neither the Company nor any ERISA Affiliate has incurred or presently expects to incur any withdrawal liability under Title IV of ERISA with respect to any multiemployer plan except for such withdrawal liability that, in the aggregate of all such liabilities, would not reasonably be expected to have a Material Adverse Effect. There

have been no “reportable events” (as such term is defined in section 4043 of ERISA) with respect to any multiemployer plan that could result in the termination of such multiemployer plan and give rise to a liability of the Company or any ERISA Affiliate in respect thereof except for such “reportable events” that, in the aggregate for all such “reportable events,” would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries has incurred or expects to incur liability under Sections 412 or 4971 of the Code, including the regulations and published interpretations thereunder; and each “pension plan” for which the Company would have any liability that is intended to be qualified under Section 401(a) of the Code has been determined by the Internal Revenue Service to be so qualified and nothing has occurred, whether by action or by failure to act, which could reasonably be expected to cause the loss of such qualification.

3.21 No Undisclosed Liabilities. There are no material liabilities of the Company or any of its Subsidiaries, other than liabilities incurred in the ordinary course of business consistent with past practice since September 30, 2005, or which in the aggregate would not reasonably be expected to result in a Material Adverse Effect.

3.22 Insurance. The Company maintains insurance of the types and in the amounts and covering such risks as is prudent and adequate for its business as currently conducted and for the value of its properties as is customary for companies engaged in similar lines of business in similar industries, all of which insurance is in full force and effect. The Company has directors and officers insurance with the carrier and in the amount set forth on Section 3.22 of the Disclosure Schedules. Neither the Company nor any of its Subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business.

3.23 Accounts Receivable. The accounts and notes receivable of the Company reflected on its balance sheet as of June 30, 2006, and all accounts and notes receivable of the Company arising subsequent to June 30, 2006, (i) arose from bona fide sales transactions in the ordinary course of business consistent with past practice and are payable on ordinary trade terms, (ii) to the knowledge of the Company and each of its Subsidiaries, are legal, valid and binding obligations of the respective debtors enforceable in accordance with their respective terms, (iii) to the knowledge of the Company and each of its Subsidiaries, are not subject to any valid set-off or counterclaim, and (iv) are not the subject of any actions or proceedings brought by or on behalf of the Company or any of its Subsidiaries.

3.24 Brokers. Except for Tejas Securities Group Inc. and RBC Capital Markets Corporation (collectively, the “Placement Agents”), neither the Company nor any of its Subsidiaries has any liability to pay any fees, commissions or other similar compensation to any broker, finder, investment banker, financial advisor or other similar Person in connection with the transactions contemplated by this Agreement.

3.25 Leases. Each of the Company and its Subsidiaries has complied with all material obligations under all leases for real property to which it is a party as a lessee. All leases

relating to the leasehold estates of each of the Company and its Subsidiaries necessary for the conduct of the business of such Person are, with respect to the Company and its Subsidiaries, valid and enforceable, and, to the knowledge of the Company, are, valid and enforceable with respect to the lessor, and each of the Company and its Subsidiaries that is the lessee in respect thereof currently enjoys peaceful and undisturbed possession of the premises subject thereto.

3.26 Intellectual Property. To the knowledge of the Company, each of the Company and its Subsidiaries owns, possesses or has the right to use all of the patents, trademarks, service marks, trade names, copyrights, franchises and licenses, and rights with respect thereto (collectively, “Intellectual Property”), necessary for the conduct of its business as described in the SEC Reports and as such business is proposed to be conducted as described in the SEC Reports, without any infringement of the rights of others. None of the Company’s Intellectual Property has expired or terminated, or is expected to expire or terminate within three (3) years from the date of this Agreement. There are no outstanding options, licenses, or agreements of any kind relating to the Company’s and/or its Subsidiaries’ Intellectual Property with the exception of agreements for the sale or license of the Company’s products or services in the ordinary course of business. Except as disclosed in the SEC Reports, the Company has not received any communications alleging that the Company or any of its Subsidiaries has violated or infringed or, by conducting its business as presently proposed, would violate or infringe any of the Intellectual Property of any other Person. Except as disclosed in the SEC Reports, there is no claim, action or proceeding being made or brought, or to the knowledge of the Company, being threatened, against the Company or its Subsidiaries regarding its Intellectual Property. Except as disclosed in the SEC Reports, the Company is unaware of any facts or circumstances which might give rise to any of the foregoing infringements or claims, actions or proceedings. To date the only patents which have issued and are now owned in all right, title and interest by the Company and/or its Subsidiaries are United States Patents Nos. 6,386,300 and 6,581,700, which United States patents are valid under United States patent laws, and United Kingdom Patent No. GB 2,385,346 issued September 8, 2004.

3.27 Environmental Compliance.

(a) Compliance. Each of the Company and its Subsidiaries is in compliance with all Environmental Protection Laws in effect in each jurisdiction where it is currently doing business and no material expenditures will be required in order to comply with any Environmental Protection Law.

(b) Liability. Neither the Company nor any of its Subsidiaries is subject to any liability under any Environmental Protection Law that, in the aggregate for all such liabilities, would reasonably be expected to have a Material Adverse Effect.

(i) notice from any Governmental Authority by which any of its currently or previously owned or leased properties has been identified in any manner by any Governmental Authority as a hazardous substance disposal or removal site, “Super Fund” clean-up site, or candidate for removal or closure pursuant to any Environmental Protection Law,

(ii) notice of any Lien arising under or in connection with any Environmental Protection Law that has attached to any revenues of, or to, any of its currently or previously owned or leased properties, or

(iii) communication, written or oral, from any Governmental Authority concerning any action or omission in connection with its currently or previously owned or leased properties resulting in the release of any hazardous substance resulting in any violation of any Environmental Protection Law,

in each case where the effect of which, in the aggregate for all such notices and communications, would reasonably be expected to have a Material Adverse Effect.

3.28 Registration Rights. Except as set forth on Section 3.28 of the Disclosure Schedules, the Company is not currently subject to any agreement providing any Person any rights (including piggyback registration rights) to have any securities of the Company or any of its Subsidiaries registered with the SEC or registered or qualified with any other Governmental Authority. Except as set forth in Section 3.28 of the Disclosure Schedules, no Person has, with respect to the Company or any of its Subsidiaries, any right to cause the Company to file any registration statement under the Securities Act.

3.29 Transactions with Affiliates and Employees. Except as disclosed in the SEC Reports, none of the officers, directors or employees of the Company (or members of any such Person’s immediate family) is presently a party to any transaction or agreement with the Company (other than for services as employees, officers and directors entered into in the ordinary course of business consistent with past practices) exceeding $60,000 in value, including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner. Except in connection with the Registration Rights Agreement or as disclosed in the SEC Reports or the Offering Memorandum, there are no agreements, understandings or proposed transactions between the Company or any of its Subsidiaries, on the one hand, and any of its officers, affiliates or directors, or any of their affiliates, on the other hand.

3.30 ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act; Internal Accounting Controls. The Company is in material compliance with all provisions of the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act of 2002 (the “▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act”) and any related rules and regulations promulgated by the SEC, which are applicable to it as of the Closing Date. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with United States generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorizations, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and its Subsidiaries have established and maintained disclosure controls and procedures (as such term is defined in

Rule 13a-14 and Rule l5d-14 under the Exchange Act); such disclosure controls and procedures are designed to ensure that material information relating to the Company and its Subsidiaries is made known to the Company’s principal executive officer and its principal financial officer by others within those entities, and such disclosure controls and procedures are effective to perform the functions for which they were established; since September 30, 2005, the Company’s auditors and the audit committee of the board of directors of the Company have been advised of: (i) any significant deficiencies in the design or operation of internal controls which could adversely affect the Company’s or its Subsidiaries’ ability to record, process, summarize, and report financial data; and (ii) any fraud, whether or not material, that involves management or other employees who have a role in the Company’s or its Subsidiaries’ internal controls; since September 30, 2005, any material weaknesses in internal controls have been identified for the Company’s auditors; since the date of the most recent evaluation of such disclosure controls and procedures, there have been no significant changes in internal controls or in other factors that could significantly affect internal controls, including any corrective actions with regard to significant deficiencies and material weaknesses; since September 30, 2005, the principal executive officer and principal financial officer of the Company have made all certifications required by the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act and any related rules and regulations promulgated by the SEC, and the statements contained in any such certification are complete and correct; and the Company and its Subsidiaries are otherwise in compliance with all applicable provisions of the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act that are effective.

3.31 Securities Laws. Subject to the accuracy of the Purchasers’ representations and warranties set forth in Section 4 below and an Investor Questionnaire executed and delivered by each Purchaser to the Company, such Investor Questionnaire in the form attached hereto as Exhibit A, the offer, sale and issuance of the Shares and the Warrants, and issuance of Warrant Shares, as provided in this Agreement and the Warrants, is and is intended to be (a) exempt from the registration requirements of the Securities Act pursuant to Section 4(2) thereof and Regulation D promulgated thereunder, and (b) exempt from registration or qualification requirements of applicable state securities laws (together, the “Securities Laws Exemptions”). Neither the Company or its Subsidiaries nor anyone acting on its or their behalf has taken any action that would cause the loss of such exemptions.

3.32 No Integrated Offering. Neither the Company, nor any Affiliate of the Company, nor any Person acting on its or their behalf has, directly or indirectly, engaged in any form of general solicitation or general advertising with respect to any security or made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the offering or issuance of the Shares, the Warrants or any Warrant Shares pursuant to this Agreement and the Warrants to be integrated with prior offerings by the Company for purposes of the Securities Act which would cause the exemptions from SEC registration upon which the Company is relying for the offering or issuance of the Shares, the Warrants or any Warrant Shares pursuant to this Agreement to be unavailable, or would cause any applicable state securities laws exemptions or any applicable stockholder approval provisions exemptions, including, without limitation, under the rules and regulations of any national securities exchange or automated quotation system on which any of the securities of the Company are listed or designated to be unavailable, nor will the Company take any action or steps that would cause the offering or issuance of the Shares, the Warrants or any Warrant Shares pursuant to this Agreement and the Warrants to be integrated with other offerings.

3.33 Interested Stockholder. To the knowledge of the Company, each Purchaser is not an “interested stockholder” (as defined in Nevada Revised Statute 78.423) of the Company as of the Closing Date, nor will a Purchaser be deemed an “interested stockholder” as a result of the consummation of the transactions contemplated herein, and the restrictions on “combinations” (as defined in Nevada Revised Statute 78.416) set forth in Nevada Revised Statute 78.438 do not apply to the transactions contemplated hereby. The Board of Directors of the Company has approved the issuance to each Purchaser of the Warrant Shares issuable upon exercise of the Warrants, and the restrictions on “combinations” set forth in Nevada Revised Statute 78.438 will not apply to any exercise of the Warrants by a Purchaser.

3.34 Application of Takeover Protections. The Company and the Board have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s charter documents or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under this Agreement, the Warrants and the Registration Rights Agreement, including without limitation the Company’s issuance of the Shares and the Purchasers’ ownership of the Shares.

3.35 Solvency. Based on the consolidated financial condition of the Company and its Subsidiaries as of the date hereof, (i) the fair saleable value of the Company’s assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities (including known and contingent liabilities) as they mature; (ii) the Company’s assets do not constitute unreasonably small capital to carry on its business for the current fiscal year as now conducted and as proposed to be conducted, including its capital needs taking into account the particular capital requirements of the business conducted by the Company, projected capital requirements and capital availability thereof; and (iii) the current cash flow of the Company, together with the proceeds the Company would receive were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its debts when such amounts are required to be paid. The Company has no present intention to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).

3.36 Disclosure. Neither this Agreement, the Registration Rights Agreement, the Warrants, the Offering Memorandum, nor any other statements or certificates made or delivered in connection herewith or therewith, when taken as a whole, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained herein or therein not misleading in light of the circumstances under which they were made.

4. Representations and Warranties of the Purchasers. In order to induce the Company to enter into this Agreement and to sell the Shares and the Warrants, each Purchaser represents and warrants, severally (as to such Purchaser only) and not jointly, as of the Closing Date, all of which shall survive the execution and delivery of this Agreement and the purchase of the Shares:

4.1 Authorization. All corporate, partnership or limited liability company action on the part of such Purchaser necessary for the authorization, execution, delivery and performance of this Agreement and the Registration Rights Agreement, and the consummation of the transactions contemplated herein and therein, has been taken. When executed and delivered by such Purchaser, each of this Agreement and the Registration Rights Agreement will constitute the legal, valid and binding obligation of such Purchaser, enforceable against such Purchaser in accordance with its terms, except as such may be limited by bankruptcy, insolvency, reorganization or other laws affecting creditors’ rights generally and by general equitable principles. Such Purchaser has all requisite corporate, partnership or limited liability company power and authority to enter into each of this Agreement and the Registration Rights Agreement, and to carry out and perform its obligations under the terms hereof and thereof.

4.2 Purchase Entirely for Own Account. Such Purchaser is acquiring the Shares and Warrants for its own account and not for resale or with a view to any resale, fractionalization, division, or distribution thereof in violation of the Securities Act. Such Purchaser has no contract, undertaking, agreement, understanding or arrangement with any person to sell, transfer, or pledge to any person any part or all of the Shares, Warrants or Warrant Shares which such Purchaser is acquiring, or any interest therein, and has no present plans to enter into the same (other than margin security agreements with a registered broker-dealer in the ordinary course of business). The Shares and Warrants were offered or sold to such Purchaser by means of a direct solicitation by the Company and one or both of the Placement Agents.

4.3 Investor Status; Etc. Such Purchaser certifies and represents to the Company that (i) it is an “accredited investor” as defined in Rule 501 of Regulation D promulgated under the Securities Act and was not organized for the purpose of acquiring any of the Shares or the Warrants and (ii) such Purchaser’s Investor Questionnaire is complete and correct. Such Purchaser’s financial condition is such that it is able to bear the risk of holding the Shares for an indefinite period of time and the risk of loss of its entire investment. Such Purchaser has sufficient knowledge and experience in investing in companies similar to the Company so as to be able to evaluate the risks and merits of its investment in the Company. Such Purchaser fully understands that the Shares, Warrants and Warrant Shares are speculative investments which involve a high degree of risk of loss of such Purchaser’s entire investment. No Person, other than the Company, the placement agent or their authorized representatives, has offered the Shares and Warrants to such Purchaser.

4.4 Securities Not Registered. Such Purchaser understands that none of the Shares, the Warrants nor the Warrant Shares have been registered under the Securities Act, by reason of their issuance by the Company in a transaction exempt from the registration requirements of the Securities Act, and that each of such securities must continue to be held by such Purchaser unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such registration. Such Purchaser understands that the exemptions from registration

afforded by Rule 144 (the provisions of which are known to it) promulgated under the Securities Act depend on the satisfaction of various conditions, and that, if applicable, Rule 144 may afford the basis for sales only in limited amounts. Such Purchaser has had an opportunity to ask questions of and receive answers from the management and authorized representatives of the Company, and to review any other relevant documents and records concerning the business of the Company and the terms and conditions of this investment, and that any such questions have been answered to such Purchaser’s full satisfaction. Such Purchaser understands that no federal or state agency has passed upon or made any recommendation or endorsement of an investment in the Shares or Warrants.

4.5 No Violation. Neither the execution, delivery and performance by such Purchaser of this Agreement and the Registration Rights Agreement nor compliance with the terms and provisions hereof and thereof by such Purchaser (a) will contravene any applicable provision of any law, statute, rule, regulation, order, writ, injunction or decree of any court or Governmental Authority, except as would not have a material adverse effect on such Purchaser’s ability to consummate the transactions contemplated hereby; or (b) will violate any provision of the organizational documents of such Purchaser, except as would not have a material adverse effect on such Purchaser’s ability to consummate the transactions contemplated hereby.

4.6 Brokers. Such Purchaser has not retained, utilized or been represented by any broker or finder in connection with the transactions contemplated by this Agreement.

4.7 Consents. All consents, approvals, orders and authorizations required on the part of such Purchaser in connection with the execution, delivery or performance of this Agreement and the consummation of the transactions contemplated herein have been obtained and are effective as of the date hereof.

4.8 Disclosure of Information. Such Purchaser has relied on its own examination of the Company, including the merits and risks involved in making an investment decision with respect to the Shares and Warrants. Such Purchaser believes it has received all the information it considers necessary or appropriate for deciding whether to purchase the Shares and Warrants. Such Purchaser further acknowledges that it has reviewed the Offering Memorandum and that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of the Shares and Warrants and the business, properties, prospects and financial condition of the Company. The foregoing does not, however, limit or modify the representations and warranties of the Company set forth in Article III of this Agreement or the rights of the Purchasers to rely thereon.

4.9 Short Sales and Confidentiality Prior to The Date Hereof. During the last thirty (30) days prior to the date hereof, neither such Purchaser nor any Affiliate of such Purchaser, foreign or domestic, has, directly or indirectly, effected or agreed to effect any Short Sale, whether or not against the box, established any “put equivalent position” (as defined in Rule 16a-1(h) under the Exchange Act) with respect to the Common Stock, borrowed or pre-borrowed any shares of Common Stock, or granted any other right (including, without limitation, any put or call option) with respect to the Common Stock or with respect to any security that includes, relates to or derived any significant part of its value from the Common Stock or otherwise sought to hedge its position in the Securities (each, a “Prohibited Transaction”).

Notwithstanding the foregoing, (i) in the case of a Purchaser and/or its Affiliates that is, individually or collectively, a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s or Affiliates assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s or Affiliates assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio managers that have knowledge about the financing transaction contemplated by this Agreement and (ii) in the case of LB I Group Inc., the representation set forth in this Section 4.9 shall only apply with respect to the Equity Strategies Group - Opportunity Fund of ▇▇▇▇▇▇ Brothers Holdings Inc. and not to any other persons, affiliates or affiliated or associated business units thereof. Such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction) other than to other Persons that are a party to this Agreement.

4.10 Affiliations with Broker-Dealers. Such Purchaser is not itself, or is not otherwise an affiliate of, a broker-dealer registered pursuant to Section 15 of the Exchange Act; provided, however, that if such Purchaser is itself, or is otherwise an affiliate of, a broker-dealer, then such Purchaser, at the time of purchase of the Shares, did not have any direct or indirect agreements or understandings with any Person to distribute the Shares. For purposes of the preceding sentence, an affiliate of a broker-dealer is any Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, a broker-dealer, and does not include any individuals employed by such broker-dealer or its affiliates.

5. Conditions Precedent.

5.1 Conditions to the Obligation of the Purchasers to Consummate the Closing. The obligation of each Purchaser to consummate the Closing and to purchase and pay for the Shares and Warrants to be purchased by it is subject to the satisfaction (or waiver by such Purchaser) of the following conditions precedent:

(a) The representations and warranties of the Company contained herein shall be true and correct in all respects on and as of the Closing Date with the same force and effect as though made on and as of the Closing Date. The Company shall have performed all obligations and conditions herein required to be performed or complied with by the Company on or prior to the Closing Date.

(b) There shall have been no event or events which has occurred since the date hereof that taken individually or in the aggregate could reasonably be expected to have a Material Adverse Effect.

(c) No proceeding challenging this Agreement, the Warrants or the Registration Rights Agreement, or the transactions contemplated hereby or thereby, or seeking to prohibit, alter, prevent or materially delay the Closing, shall have been instituted before any court, arbitrator or Governmental Authority or official or shall be pending against or involving the Company or any of its Subsidiaries.

(d) The sale of the Shares and Warrant Shares and the issuance of the Warrants to the Purchasers shall not be prohibited by any law, rule, governmental order or regulation. All necessary consents, approvals, licenses, permits, orders and authorizations of, or registrations, declarations and filings with, any Governmental Authority or of or with any other Person with respect to any of the transactions contemplated hereby shall have been duly obtained or made and shall be in full force and effect.

(e) The Purchasers shall have received from ▇▇▇▇▇▇ & ▇▇▇▇▇▇ LLP, outside counsel to the Company, an opinion addressed to such Purchasers, dated the Closing Date and substantially in the form of Exhibit B-1 hereto.

(f) The Purchasers shall have received from ▇▇▇▇▇▇▇▇ and Wedge, outside Nevada counsel to the Company, an opinion addressed to such Purchasers, dated the Closing Date and substantially in the form of Exhibit B-2 hereto.

(g) The Registration Rights Agreement shall have been executed and delivered to the Purchasers by the Company.

(h) The Company shall have delivered to the Purchasers a certificate substantially in the form of Exhibit C hereto dated the Closing Date and signed by the secretary or another officer of the Company, certifying (i) that the copies of the certificate of incorporation (or other charter documents), the by-laws and resolutions of the Board approving this Agreement, the Warrants, the Registration Rights Agreement and the transactions contemplated hereby and thereby attached thereto, are all true, complete and correct and remain in full force and effect as of such date, and (ii) as to the incumbency and specimen signature of each officer of the Company executing this Agreement, the Warrants, the Registration Rights Agreement and any other document delivered in connection herewith on behalf of the Company.

(i) The Company shall have delivered to the Purchasers a certificate substantially in the form of Exhibit D hereto dated the Closing Date and signed by the Company’s chief financial officer, certifying that (i) the representations and warranties of the Company contained in Section 3 hereof are true and correct in all respects on the Closing Date and (ii) the Company has performed and complied with all of the agreements and conditions set forth or contemplated herein that are required to be performed or complied with by the Company on or before the Closing Date.

(j) The Company shall have delivered to the Purchasers a certificate of good standing for the Company and each of its Subsidiaries issued by the Secretary of State of its applicable state of incorporation or organization, and, with respect to the Company a certificate of qualification to do business issued by the Secretary of State of the State of Texas.

(k) The Purchasers shall have received a copy of the duly executed Transfer Agent Instruction Letter in the form of Exhibit E hereto.

(l) All instruments and corporate proceedings of the Company in connection with the transactions contemplated by this Agreement, the Warrants and the Registration Rights Agreement shall be reasonably satisfactory in form and substance to such Purchaser, and such Purchaser shall have received copies (executed or certified, as may be appropriate) of all

documents which any Purchaser may have reasonably requested in connection with such transactions.

5.2 Conditions to the Obligation of the Company to Consummate the Closing. The obligation of the Company to consummate the Closing and to issue and sell the Shares and Warrants to each Purchaser at the Closing is subject to the satisfaction of the following conditions precedent:

(a) The representations and warranties of such Purchaser contained herein shall be true and correct in all respects on and as of the Closing Date.

(b) The Registration Rights Agreement shall have been executed and delivered to the Company by such Purchaser.

(c) Such Purchaser shall have performed all obligations and conditions herein required to be performed or complied with by such Purchaser on or prior to the Closing Date, including but not limited to tendering its respective portion of the Aggregate Purchase Price.

(d) No proceeding challenging this Agreement, the Warrants or the Registration Rights Agreement, or the transactions contemplated hereby or thereby, or seeking to prohibit, alter, prevent or materially delay the Closing, shall have been instituted before any court, arbitrator or Governmental Authority or official or shall be pending against or involving such Purchaser.

(e) The sale of the Shares and the Warrants by the Company shall not be prohibited by any law, rule, governmental order or regulation. All necessary consents, approvals, licenses, permits, orders and authorizations of, or registrations, declarations and filings with, any Governmental Authority or of any other Person with respect to any of the transactions contemplated hereby shall have been duly obtained or made and shall be in full force and effect.

(f) Such Purchaser shall have delivered to the Company a completed Investor Questionnaire in the form of Exhibit A hereto.

6. Certain Covenants and Agreements.

6.1 Transfer of Securities; Limitation on Short Sales.

(a) Each Purchaser agrees severally (as to itself only) and not jointly that it shall not sell, assign, pledge, transfer or otherwise dispose of or encumber any of the Shares, the Warrants or the Warrant Shares except: (i) pursuant to an effective registration statement under the Securities Act; (ii) to an Affiliate of such Purchaser (so long as such Affiliate agrees to certify that it is an “accredited investor” as defined in Rule 501(a) under the Securities Act and to be bound by the terms and provisions of this Agreement as if, and to the fullest extent as, such Purchaser) or to partners or members in a pro rata distribution in accordance with such Purchaser’s existing governance documents (so long as such distribution is not presently contemplated and such partner or member agrees in a written instrument in form and substance reasonably satisfactory to the Company to be bound by the terms and provisions of this Agreement as if, and to the fullest extent as, such Purchaser); or (iii) pursuant to an available

exemption from registration under the Securities Act (including sales permitted pursuant to Rule 144) and applicable state securities laws, so long as the transferee (other than in sales permitted pursuant to Rule 144) agrees in a written instrument in form and substance reasonably satisfactory to the Company to be bound by the terms and provisions of this Agreement as if, and to the fullest extent as, such Purchaser). If the Company requests an opinion of counsel for such transferor that the proposed transfer may be effected without registration of such Shares, the Warrants or the Warrant Shares under the Securities Act (including sales permitted pursuant to Rule 144), such transferor shall not be entitled to effect such transfer unless and until the Company receives such an opinion of counsel (which counsel and opinion shall each be reasonably satisfactory to the Company).

(b) Prior to the earliest to occur of (A) the termination of this Agreement, (B) the Effective Date or (C) the Mandatory Effective Date, such Purchaser shall not, and shall cause its Affiliates not to, engage, directly or indirectly, in (i) a Prohibited Transaction or (ii) any sale, assignment, pledge, hypothecation, put, call, or other transfer of any of the shares of Common Stock, warrants or other securities of the Company acquired hereunder (except as collateral security for a margin agreement with a registered broker-dealer entered into in the ordinary course of business). Notwithstanding the foregoing, (x) in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio managers that have knowledge about the financing transaction contemplated by this Agreement and (y) in the case of LB I Group Inc., this Section 6.1(b) shall only apply with respect to the Equity Strategies Group - Opportunity Fund of ▇▇▇▇▇▇ Brothers Holdings Inc. and not to any other persons, affiliates or affiliated or associated business units thereof. Each Purchaser further understands and acknowledges severally (as to itself only) and not jointly that the Staff of the SEC has publicly stated the position in Item 65, Section A, of the Manual of Publicly Available Telephone Interpretations, dated July 1997, that securities underlying a short position are deemed to be sold at the time such short position is established and, therefore, according to the SEC, the use by a Purchaser of Shares or Warrant Shares to cover a short position is a violation of Section 5 of the Securities Act unless such Shares or Warrant Shares, as the case may be, are not restricted under the Securities Act at the time such short position is established.

(c) Any transfer or purported transfer of the Shares in violation of this Section 6.1 or Section 6.2 shall be void. The Company shall not register any transfer of the Shares in violation of this Section 6.1 or Section 6.2. The Company may, and may instruct any transfer agent for the Company, to place such stop transfer orders as may be required on the transfer books of the Company in order to ensure compliance with the provisions of this Section 6.1 and Section 6.2.

6.2 Legends.

(a) To the extent applicable, each certificate or other document evidencing the Shares, the Warrants or the Warrant Shares shall be endorsed with the legend set forth below, and each Purchaser covenants that, except to the extent such restrictions are waived by the

Company, it shall not transfer the securities represented by any such certificate without complying with the restrictions on transfer described in this Agreement and the legends endorsed on such certificate:

[NEITHER] THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS [EXERCISABLE] [CONVERTIBLE]] HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. IN ADDITION, THE TRANSFER HEREOF IS SUBJECT TO VARIOUS AGREEMENTS CONTAINED IN A SECURITIES PURCHASE AGREEMENT DATED OCTOBER 19, 2006. A COPY OF SUCH AGREEMENT WILL BE PROVIDED TO THE HOLDER UPON REQUEST. THIS SECURITY AND THE SECURITIES ISSUABLE UPON [EXERCISE] [CONVERSION] OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the securities to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement and the Registration Rights Agreement and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Company securities may reasonably request in connection with a pledge or transfer of the securities, including, if the securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling stockholders thereunder.

(b) The Company agrees, upon a Purchaser’s reasonable request, to reissue certificates representing any of the Shares or Warrant Shares, without the legend set forth in Section 6.2(a) above (i) when a registration statement (including the Mandatory Registration Statement to be filed pursuant to the Registration Rights Agreement) providing for the resale of such Shares and Warrant Shares is declared effective under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 (assuming the transferor is not an Affiliate of the Company), (iii) if such Shares or Warrant Shares are eligible for sale under Rule

144(k) (to the extent that such Purchaser provides a certification or legal opinion to the Company to that effect), or (iv) if such legend is not required under applicable requirements of the Securities Act (including controlling judicial interpretations and pronouncements issued by the SEC). Following the Effective Date or at such earlier time as a legend is no longer required for the Shares or the Warrant Shares, the Company will, promptly following the delivery by a Purchaser to the Company or the Company’s transfer agent of a legended certificate representing such Shares or Warrant Shares, deliver or cause to be delivered to such Purchaser a certificate representing such Shares or Warrant Shares that is free from all restrictive legends. The restrictions on transfer contained in this Section 6.1 shall be in addition to, and not by way of limitation of, any other restrictions on transfer contained in any other section of this Agreement. Whenever a certificate representing the Shares or Warrant Shares is required to be issued to a Purchaser without a legend, in lieu of delivering physical certificates representing the Shares or Warrant Shares, provided the Company’s transfer agent is participating in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer program, the Company shall cause its transfer agent to electronically transmit the Shares or Warrant Shares to a Purchaser in accordance with any written instructions provided by such Purchaser by crediting the account of such Purchaser’s Prime Broker with DTC through its Deposit Withdrawal Agent Commission (“DWAC”) system (to the extent not inconsistent with any provisions of this Agreement).

(c) Each Purchaser, severally and not jointly with the other Purchasers, agrees that the removal of the restrictive legend from certificates representing securities as set forth in this Section 6.2 is predicated upon the Company’s reliance that the Purchaser will sell any securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom, and that if securities are sold pursuant to a registration statement, they will be sold in compliance with the plan of distribution set forth therein.

6.3 Publicity. Except to the extent required by applicable laws, rules, regulations or stock exchange requirements, the Company, its Subsidiaries and their Affiliates shall not, without the written consent of the Majority Purchasers, make any public announcement or issue any press release with respect to the transactions contemplated by this Agreement; provided that the Company, each of its Subsidiaries and their respective Affiliates shall not, without the prior written consent of the Purchaser, disclose or publish the name of such Purchaser in any such press release or public announcement. Except to the extent required by applicable laws, rules, regulations or stock exchange requirements, the Purchasers and their Affiliates shall not, without the written consent of the Company make any public announcement or issue any press release with respect to the transactions contemplated by this Agreement. In no event will either (i) the Company, its Subsidiaries or any of their Affiliates or (ii) any Purchaser or any of its Affiliates make any public announcement or issue any press release with respect to the transactions contemplated by this Agreement without consulting with the Company, on the one hand, and Tejas Securities Group, Inc. and RBC Capital Markets, as co-placement agents, on the other hand, to the extent possible, as to the content of such public announcement or press release. Notwithstanding the foregoing, the parties agree that the Company shall issue a press release in the form of Exhibit F hereto promptly following (and in no event more than 24 hours after) the Closing and, on or before 9:00 a.m., New York time, on the first trading day following the Closing Date, the Company shall file a Current Report on Form 8-K describing the terms of

the transactions contemplated by this Agreement, the Warrants and the Registration Rights Agreement in the form required by the Exchange Act, and attaching the material transaction documents (including, without limitation, this Agreement (and all schedules to this Agreement) and the Registration Rights Agreement) as exhibits to such filing (including all attachments, the “8-K Filing”). From and after the filing of the 8-K Filing with the SEC, the Company shall use commercially reasonable efforts to assure that, and shall cause each of its Subsidiaries and each of their respective officers, directors, employees and agents to use commercially reasonable efforts to assure that, no Purchaser shall be in possession of any material, nonpublic information received from the Company, any of its Subsidiaries or any of its respective officers, directors, employees or agents, that is not disclosed in the 8-K Filing. The Company shall not, and shall cause each of its Subsidiaries and each of their respective officers, directors, employees and agents, not to, provide any Purchaser with any material nonpublic information regarding the Company or any of its Subsidiaries from and after the filing of the 8-K Filing with the SEC without the express written consent of such Purchaser; provided that the Company shall not be responsible for any information obtained by any Purchaser or any Inspector (as defined in the Registration Rights Agreement) as a result of such Purchaser’s exercise of its inspection rights under the Registration Rights Agreement; and provided further that in the event the Company or any of its Subsidiaries provides any information to a Purchaser under the Registration Rights Agreement and the Company reasonably believes that such information represents material nonpublic information, the Company (a) shall prior to such disclosure to any Purchaser notify such Purchaser of such belief and shall not provide such information to any Purchaser which does not expressly consent to receive such information and (b) to the extent any Purchaser determines not to receive such information, the Company shall be deemed not to be in breach of the original obligation to provide such information. In the event of a breach of the foregoing covenant by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees and agents, in addition to any other remedy provided herein or in the Registration Rights Agreement, a Purchaser shall have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material non-public information without the prior approval by the Company, its Subsidiaries, or any of its or their respective officers, directors, employees or agents; provided that the Purchaser will provide to the Company two (2) Business Days’ advance notice prior to such disclosure, and shall refrain from making such disclosure if the Company makes such disclosure during such two-day period. No Purchaser shall have any liability to the Company, its Subsidiaries, or any of its or their respective officers, directors, employees, shareholders or agents for any such disclosure made in compliance with this Section 6.3.

6.4 Use of Proceeds. The Company covenants and agrees that the proceeds from the sale of the Shares shall be used by the Company for the purposes described in the Offering Memorandum.

6.5 Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Shares or Warrants in a manner that would require the registration under the Securities Act of the sale of the Shares to the Purchasers.

6.6 Reservation of Common Stock for Issuance; Listing of Shares. The Company agrees to reserve from its duly authorized capital stock the total number of shares of

Common Stock issuable upon execution of this Agreement and exercise of the Warrants. The Company agrees that at any time while its shares of Common Stock are listed on NASDAQ or any other securities exchange, that it will use commercially reasonable efforts to promptly list and qualify the Shares and Warrant Shares for trading on NASDAQ or such other securities exchange.

6.7 Actions with respect to Securities Laws Exemptions. Neither the Company nor anyone acting on its behalf shall take any action that would cause the loss of any Securities Laws Exemptions.

6.8 Restrictions on Certain Stock Issuances or Registrations. The Company agrees that prior to the effectiveness of the Mandatory Registration Statement (as defined in the Registration Rights Agreement), the Company shall not (i) issue any shares of Common Stock, or securities convertible into or exercisable for shares of Common Stock, that could be eligible for sale without restriction under the Securities Act prior to the effectiveness of the Mandatory Registration Statement (as defined in the Registration Rights Agreement), or (ii) grant any registration rights after the date hereof to any other Person that would entitle such Person to have the sale of securities held by such Person registered under the Securities Act by the Company under a registration statement that is declared effective prior to the effectiveness of the Mandatory Registration Statement, provided, that this Section 6.8 shall not be deemed to restrict the ability of the Company to (a) issue shares of Common Stock upon the exercise or conversion of any options, warrants, convertible debt instruments or other contingent securities outstanding on the date hereof or (b) issue shares of Common Stock, options or warrants to employees, directors or consultants of the Company.

6.9 Listing. After the Closing Date, the Company shall use commercially reasonable efforts to have the Shares and Warrant Shares listed on the Nasdaq Capital Market.

6.10 Equal Treatment of Purchasers. No consideration shall be offered or paid to any person to amend or consent to a waiver or modification of any provision of this Agreement, the Warrants or the Registration Rights Agreement unless the same consideration is also offered to all of the parties to this Agreement, the Warrants and the Registration Rights Agreement. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of the Shares or otherwise.

7. Indemnification.

7.1 By the Company. The Company, without limitation as to time, agrees to indemnify, defend and hold harmless each Purchaser and its Affiliates and their respective officers, directors, agents, employees, subsidiaries, partners, members, investment advisers and controlling persons (collectively, the “Purchaser Indemnitees”) to the fullest extent permitted by law from and against any and all claims, losses, liabilities, damages, deficiencies, judgments, assessments, fines, settlements, costs or expenses (including interest, penalties and reasonable fees, disbursements and other charges of counsel) (collectively, “Losses”) based upon, arising out of or otherwise in respect of or relating to any breach by the Company of any representation,

warranty, covenant or agreement of the Company contained in this Agreement, the Warrants or in the Registration Rights Agreement.

7.2 Applicability. Notwithstanding any term to the contrary in this Section 7, the indemnification and contribution provisions of the Registration Rights Agreement shall govern any claim made with respect to registration statements filed pursuant thereto or sales made thereunder.

8. Miscellaneous Provisions.

8.1 Rights Cumulative. Each and all of the various rights, powers and remedies of the parties shall be considered to be cumulative with and in addition to any other rights, powers and remedies which such parties may have at law or in equity in the event of the breach of any of the terms of this Agreement. The exercise or partial exercise of any right, power or remedy shall neither constitute the exclusive election thereof nor the waiver of any other right, power or remedy available to such party.

8.2 Pronouns. All pronouns or any variation thereof shall be deemed to refer to the masculine, feminine or neuter, singular or plural, as the identity of the person, persons, entity or entities may require.

8.3 Notices.

(a) Any notices, reports or other correspondence (hereinafter collectively referred to as “correspondence”) required or permitted to be given hereunder shall be sent by postage prepaid first class mail, overnight courier or facsimile transmission, or delivered by hand to the party to whom such correspondence is required or permitted to be given hereunder. The date of giving any notice shall be the date of its actual receipt.

(b) All correspondence to the Company shall be addressed as follows:

Particle Drilling Technologies, Inc.
▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇
Attn: Chief Financial Officer
Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇

with a copy to:

▇▇▇▇▇▇ & ▇▇▇▇▇▇ LLP
First City Tower
▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇-▇▇▇
Attn: W. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇

(c) All correspondence to the Purchasers shall be addressed pursuant to the contact information set forth on the signature page hereto.

(d) Any party may change the address to which correspondence to it is to be addressed by notification as provided for herein.

8.4 Captions. The captions and paragraph headings of this Agreement are solely for the convenience of reference and shall not affect its interpretation.

8.5 Severability. Should any part or provision of this Agreement be held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding upon the parties hereto.

8.6 Governing Law; Waiver of Jury Trial. This Agreement shall be governed by and construed in accordance with the internal and substantive laws of the State of New York without regard to any conflicts of laws concepts which would apply the substantive law of some other jurisdiction. THE PARTIES HEREBY IRREVOCABLY WAIVE ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT.

8.7 Waiver. No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or be construed as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition of this Agreement.

8.8 Assignment. The rights and obligations of any party hereto shall inure to the benefit of and shall be binding upon the authorized successors and permitted assigns of such party. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser. Each Purchaser may assign or transfer any or all of its rights under this Agreement to any Person provided that such assignee or transferee complies with and agrees in writing to be bound, with respect to the transferred Shares, by Sections 6.1 and 6.2 hereof; whereupon such assignee or transferee shall be deemed to be a “Purchaser” for all purposes of this Agreement.

8.9 Survival. The respective representations and warranties given by the parties hereto shall survive the Closing Date and the consummation of the transactions contemplated herein. The respective covenants and agreements agreed to by a party hereto shall survive the Closing Date and the consummation of the transactions contemplated herein in accordance with their respective terms and conditions.

8.10 Entire Agreement. This Agreement, the Warrants and the Registration Rights Agreement constitute the entire agreement between the parties hereto respecting the subject matter hereof and supersede all prior agreements, negotiations, understandings, representations and statements respecting the subject matter hereof, whether written or oral, including but not limited to the various Term Sheets dated on or about October 17, 2006 between the Company and the Purchasers. The Company agrees that in the event it enters into any agreement or understanding with any Purchaser pursuant to which the Company grants such

Purchaser any rights or other terms relating to the purchase, registration, holding or disposition of Shares, Warrants or Warrant Shares that are more favorable than those set forth herein, in the Warrants or the Registration Rights Agreement, the Company shall also grant each other Purchaser such more favorable rights or other terms.

8.11 Amendments. Any amendment, supplement or modification of or to any provision of this Agreement and any waiver of any provisions of this Agreement shall be effective only if made or given in writing and signed by the Company and the Majority Purchasers, provided, that any amendment, supplement, modification or waiver that is materially and disproportionately adverse to any Purchaser(s), when compared to all other Purchasers similarly situated, shall require the consent of such Purchaser(s).

8.12 No Third Party Rights. This Agreement is intended solely for the benefit of the parties hereto and their respective successors and permitted assigns and is not intended to confer any benefits upon, or create any rights in favor of, any Person (including, without limitation, any stockholder or debt holder of the Company) other than the parties hereto, provided, that each of the Purchaser Indemnitees that are not Purchasers are entitled to all rights and benefits as third party beneficiaries of Section 7 of this Agreement.

8.13 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same document. The parties hereto confirm that any facsimile copy (including a .pdf file) of another party’s executed counterpart of this Agreement (or its signature page thereof) will be deemed to be an executed original thereof.

8.14 Exculpation Among Purchasers. Each Purchaser acknowledges that it is not relying upon any Person (including, without limitation, any other Purchaser), other than the Company and its officers and directors (acting in their capacity as representatives of the Company), in deciding to invest and in making its investment in the Company. Each Purchaser agrees that no other Purchaser nor the respective controlling persons, officers, directors, partners, agents or employees of any other Purchaser shall be liable to such Purchaser for any losses incurred by such Purchaser in connection with its investment in the Company.

8.15 Expenses. Each party hereto will bear its own fees and expenses in connection with the transactions contemplated by this Agreement, the Warrants and the Registration Rights Agreement.

[Signature pages follow.]

Each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered as of the date first written above.

THE COMPANY:

	PARTICLE DRILLING TECHNOLOGIES, INC.


	By:			/s/ ▇▇▇ ▇. ▇▇▇▇▇
	Name:			▇▇▇ ▇. ▇▇▇▇▇
	Title:			President and Chief Executive Officer

THE PURCHASERS:

	NAME OF PURCHASER


	(please print name exactly as it should appear on certificates)


	By:
	Name:
	Title:

Number of Shares Purchased

Purchase Price	$

Number of Warrant Shares Subject to Warrant


Address for Notice



	Facsimile:	( ) -

LIST OF EXHIBITS

Exhibit A:		Form of Investor Questionnaire
Exhibit B-1:		Form of Legal Opinion of ▇▇▇▇▇▇ & ▇▇▇▇▇▇ LLP
Exhibit B-2:		Form of Legal Opinion of ▇▇▇▇▇▇▇▇ and Wedge
Exhibit C:		Form of Secretary’s Certificate
Exhibit D:		Form of Officer’s Certificate
Exhibit E:		Form of Transfer Agent Instructions
Exhibit F:		Form of Company Press Release

SCHEDULE I LIST OF PURCHASERS

Name of Shareholder	Address	Number of Shares	Number of Warrant Shares
Cadence Master, Ltd.	Cadence Investment Management, LLC ▇▇▇ ▇▇▇ ▇▇▇. ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇	250,000	75,000
Milfam I, L.P.	▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇	100,000	30,000
U.S.A. Fund, LLLP	▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇	200,000	60,000
The IBS Turnaround Fund (QP) (A Limited Partnership)	▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	228,200	68,460
The IBS Opportunity Fund (BVI), Ltd.	c/o IBS Capital Corp. ▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	47,300	14,190
The IBS Turnaround Fund, L.P.	▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	74,500	22,350
Greywolf Capital Partners II LP	▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇	155,000	46,500
Greywolf Capital Overseas Fund	▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇	345,000	103,500
▇▇▇▇▇ ▇▇▇▇▇▇	c/o Romulus Holdings, Inc. ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇	100,000	30,000
SF Capital Partners Ltd.	c/▇ ▇▇▇▇▇ Offshore Management, LLC Attn: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇. ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇	400,000	120,000
LB I Group Inc.	Attn: ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ Brothers ▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ Ref: Account #931-17559-1-3	237,000	71,100
Millennium Partners, L.P.	c/o Millennium Management, L.L.C. ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇ ▇▇▇▇▇▇ & ▇▇▇ ▇▇▇▇▇▇▇▇	625,000	187,500
Fort ▇▇▇▇▇ Partners, LP	▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ & ▇▇ ▇▇▇▇▇	64,737	19,421
Fort ▇▇▇▇▇ Master, LP	▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ & ▇▇ ▇▇▇▇▇	998,263	299,479
LC Capital Master Fund, Ltd.	c/o ▇▇▇▇▇ ▇▇▇▇▇▇ & Co. LLC ▇▇▇ ▇▇▇▇▇ ▇▇▇., ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇	625,000	187,500
▇▇▇▇▇▇▇▇▇▇▇▇ Qualified Associates, LP	▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇	250,000	75,000
Phaeton International (BVI) Limited	▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 1221 Avenue of the Americas 28th Floor attn: ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ A/C# 038-30003	125,100	37,530
Phoenix Partners II, ▇.▇.	▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 1221 Avenue of the Americas 28th Floor attn: ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ A/C# 038-51032	36,900	11,070
Phoenix Partners ▇.▇.	▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 1221 Avenue of the Americas 28th Floor attn: ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ A/C# 038-30014	138,000	41,400

PARTICLE DRILLING TECHNOLOGIES, INC. SECURITIES PURCHASE AGREEMENT

Document Metadata

Document Metadata

Table of Contents